Case Updates
U.S. Chamber files amicus brief urging Fifth Circuit to affirm district court decision dismissing claims against vaccine manufacturer as barred by the Public Readiness and Emergency Preparedness (PREP) Act
June 23, 2025
The Act’s immunity and preemption provisions broadly preclude claims targeting the marketing and promotion of covered products, along with other claims.
Jeffrey S. Bucholtz and Matthew V.H. Noller of King & Spalding LLP served as outside counsel.